Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$244K Sell
1,098
-253
-19% -$46K 0.01% 703
2026
Q1
$208K Sell
1,351
-2,939
-69% -$399K ﹤0.01% 1095
2025
Q4
$487K Buy
+4,290
New +$522K 0.01% 474
2025
Q3
Sell
-1,487
Closed -$212K 1361
2025
Q2
$212K Buy
+1,487
New +$211K ﹤0.01% 937
2024
Q4
Sell
-1,318
Closed -$216K 635
2024
Q3
$216K Buy
+1,318
New +$195K 0.01% 497
2021
Q4
Sell
-22,300
Closed -$2.59M 265
2021
Q3
$2.59M Buy
+22,300
New +$2.79M 0.11% 69

Other funds holding DVA

DRW Securities's DVA Position: Q2 2026 in Review

DRW Securities reduced its DaVita (DVA) stake by 19% in Q2 2026, selling an estimated $46K and leaving 1,098 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #703.

DRW Securities first reported a position in DVA in Q3 2021 and has held it in 6 quarters since. The position peaked at $2.59M in Q3 2021. 631 funds tracked by Wall St. Rank hold DVA as of Q2 2026.

  • DRW Securities held 1,098 shares of DaVita worth $244K as of Q2 2026.
  • DRW Securities sold 253 DaVita shares in Q2 2026, an estimated $46K.
  • DaVita made up 0.01% of DRW Securities's portfolio in Q2 2026, its #703 holding.
  • DRW Securities first reported a position in DaVita in Q3 2021 and has held it in 6 quarters since.
  • DRW Securities's DaVita position peaked at $2.59M in Q3 2021.
  • 631 funds tracked by Wall St. Rank held DaVita as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.